Self Injection Device Market to Enjoy 'Explosive Growth' to 2025: Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly, Gerresheimer, Dongbao
HTF MI recently introduced Global Self Injection Device Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly, Gerresheimer, Dongbao, Ypsomed, Owen Mumford, Antares Pharma & Haselmeier etc.
View full press release